- Home
- NRSN vs LIQT Comparison
NRSN vs LIQT Comparison
Compare NRSN & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- LIQT
- Stock Information
- Founded
- NRSN 2017
- LIQT 2004
- Country
- NRSN Israel
- LIQT Denmark
- Employees
- NRSN N/A
- LIQT N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- NRSN Health Care
- LIQT Technology
- Exchange
- NRSN Nasdaq
- LIQT Nasdaq
- Market Cap
- NRSN 17.8M
- LIQT 16.9M
- IPO Year
- NRSN 2021
- LIQT N/A
- Fundamental
- Price
- NRSN $1.09
- LIQT $1.81
- Analyst Decision
- NRSN Hold
- LIQT Strong Buy
- Analyst Count
- NRSN 1
- LIQT 2
- Target Price
- NRSN N/A
- LIQT $4.60
- AVG Volume (30 Days)
- NRSN 374.5K
- LIQT 20.3K
- Earning Date
- NRSN 12-18-2024
- LIQT 11-14-2024
- Dividend Yield
- NRSN N/A
- LIQT N/A
- EPS Growth
- NRSN N/A
- LIQT N/A
- EPS
- NRSN N/A
- LIQT N/A
- Revenue
- NRSN N/A
- LIQT $15,128,295.00
- Revenue This Year
- NRSN N/A
- LIQT N/A
- Revenue Next Year
- NRSN N/A
- LIQT $31.19
- P/E Ratio
- NRSN N/A
- LIQT N/A
- Revenue Growth
- NRSN N/A
- LIQT N/A
- 52 Week Low
- NRSN $0.51
- LIQT $1.51
- 52 Week High
- NRSN $2.33
- LIQT $3.55
- Technical
- Relative Strength Index (RSI)
- NRSN 47.35
- LIQT 47.29
- Support Level
- NRSN $1.01
- LIQT $1.75
- Resistance Level
- NRSN $1.13
- LIQT $1.92
- Average True Range (ATR)
- NRSN 0.09
- LIQT 0.13
- MACD
- NRSN -0.01
- LIQT -0.01
- Stochastic Oscillator
- NRSN 27.27
- LIQT 28.12
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.